News Medical on MSN1 小时
Pioneering study discovers new genetic links to pancreatic cancer in Brazil
Pancreatic cancer has recently been included in the list of diseases about which Brazil's National Cancer Institute (INCA) ...
Immunovia announces positive outcome and strong accuracy in the clinical validation of its ...
Immunovia (STO: IMMNOV), the pancreatic cancer diagnostics company, today announces the successful completion of the CLARITI study, (Clinical Validation of Next-Generation Test for Early-Stage ...
A pair of enzymes provides insights in how pancreatic cancer cells adapt when resources are ...
Cancer cells are like booming cities without urban planners. They expand quickly, and in doing so, the resulting tumors ...
Merus Scores Its First FDA Approval For Lung Cancer Drug
FDA approves Merus' Bizengri as the first treatment for advanced NRG1 fusion-positive cancers. U.S. peak sales are estimated ...
Business Wire11 天
European Commission Approves BeiGene’s TEVIMBRA for First-Line Treatment of Advanced ...
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne ...
FDA Grants Accelerated Approval For Merus' BIZENGRI For Pancreatic Adenocarcinoma And NSCLC
Merus N.V. (MRUS) announced that the U.S. Food and Drug Administration has granted accelerated approval for BIZENGRI ...
Merus gets FDA approval of BIZENGRI in NRG1+ Pancreatic Adenocarcinoma, NSCLC
Merus (MRUS) announced that the FDA approved BIZENGRI(R) (zenocutuzumab-zbco), the first and only treatment indicated for ...
Pharmabiz3 天
Merus’ Bizengri receives US FDA approval to treat pancreatic adenocarcinoma or non ...
Merus’ Bizengri receives US FDA approval to treat pancreatic adenocarcinoma or non–small cell lung cancer: Utrecht, The Netherlands Friday, December 6, 2024, 15:30 Hrs [IST] M ...